메뉴 건너뛰기




Volumn 2, Issue 1, 2011, Pages 59-64

Central serous chorioretinopathy with subretinal deposition of fibrin-like material and its prompt response to ranibizumab injections

Author keywords

Central serous chorioretinopathy; Fibrin; Optical coherence tomography; Ranibizumab

Indexed keywords

RANIBIZUMAB;

EID: 79957592130     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000324701     Document Type: Article
Times cited : (17)

References (6)
  • 3
    • 0029125653 scopus 로고
    • Subretinal fibrosis in central serous chorioretinopathy
    • Schatz H, McDonald HR, et al: Subretinal fibrosis in central serous chorioretinopathy. Ophthalmology 1995;102:1077-1088.
    • (1995) Ophthalmology , vol.102 , pp. 1077-1088
    • Schatz, H.1    McDonald, H.R.2
  • 4
    • 77957603471 scopus 로고    scopus 로고
    • Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy
    • Konstantinidis L, Mantel I, Zografos L, Ambresin A: Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy. Eur J Ophthalmol 2010;20:955-958.
    • (2010) Eur J Ophthalmol , vol.20 , pp. 955-958
    • Konstantinidis, L.1    Mantel, I.2    Zografos, L.3    Ambresin, A.4
  • 6
    • 77957360007 scopus 로고    scopus 로고
    • VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: Possible participation of intracellular glutathione
    • Miura Y, Klettner A, Roider J: VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: Possible participation of intracellular glutathione. Invest Ophthalmol Vis Sci 2010;51:4848-4855.
    • (2010) Invest Ophthalmol Vis Sci , vol.51 , pp. 4848-4855
    • Miura, Y.1    Klettner, A.2    Roider, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.